Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity

被引:13
作者
Hikri, Elad [1 ]
Shpungin, Sally [1 ]
Nir, Uri [1 ]
机构
[1] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel
关键词
Hsp90; Fer; Kinase activity; Phosphorylation; CELL-ADHESION; CORTACTIN PHOSPHORYLATION; CHAPERONE COMPLEX; PROTEIN FUNCTION; P120; CATENIN; SRC-KINASE; ACTIVATION; ASSOCIATION; BINDING; GELDANAMYCIN;
D O I
10.1016/j.cellsig.2008.12.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hsp90 is a key regulator of tyrosine kinases activity and is therefore considered as a promising target for intervention with deregulated signaling pathways in malignant cells. Here we describe a novel Hsp90 client the intracellular tyrosine kinase, Fer, which is subjected to a unique regulatory regime by this chaperone. Inhibition of Hsp90 activity led to proteasomal degradation of the Fer enzyme. However, circumventing the dependence of Fer accumulation on Hsp90, revealed the dependence of the Fer kinase activity and its ability to phosphorylate Stat3 on the chaperon, expressing the necessity of Hsp90 for its function. Mutation analysis unveiled a tyrosine (Tyr(616)) embedded in the Hsp90 recognition loop, which is required for the kinase activity of Fer. Replacement of this tyrosine by phenylalanine (Y616F) disabled the auto-phosphorylation activity of Fer and abolished its ability to phosphorylate Stat3. Notably, surrounding the replaced Y616F with subtle mutations restored the auto and trans-phosphorylation activities of Fer suggesting that Y-616 is not itself an essential auto-phosphorylation site of the kinase. Taken together, our results portray Hsp90 and its recognition loop as novel positive regulators of the Fer tyrosine kinase stability and activity. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 46 条
  • [1] Links between Fer tyrosine kinase expression levels and prostate cell proliferation
    Allard, P
    Zoubeidi, A
    Nguyen, LT
    Tessier, S
    Tanguay, S
    Chevrette, M
    Aprikian, A
    Chevalier, S
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 159 (1-2) : 63 - 77
  • [2] An WG, 2000, CELL GROWTH DIFFER, V11, P355
  • [3] An Woojin, 2007, Subcell Biochem, V41, P351
  • [4] Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
    Basso, AD
    Solit, DB
    Munster, PN
    Rosen, N
    [J]. ONCOGENE, 2002, 21 (08) : 1159 - 1166
  • [5] Arginine methylation: An emerging regulator of protein function
    Bedford, MT
    Richard, S
    [J]. MOLECULAR CELL, 2005, 18 (03) : 263 - 272
  • [6] Ben-Dor I, 1999, CELL GROWTH DIFFER, V10, P113
  • [7] Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56lck
    Bijlmakers, MJJE
    Marsh, M
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (05) : 1585 - 1595
  • [8] Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
    Citri, A
    Gan, J
    Mosesson, Y
    Vereb, G
    Szollosi, J
    Yarden, Y
    [J]. EMBO REPORTS, 2004, 5 (12) : 1165 - 1170
  • [9] Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
    Citri, A
    Alroy, I
    Lavi, S
    Rubin, C
    Xu, WP
    Grammatikakis, N
    Patterson, C
    Neckers, L
    Fry, DW
    Yarden, Y
    [J]. EMBO JOURNAL, 2002, 21 (10) : 2407 - 2417
  • [10] Hsp90 recognizes a common surface on client kinases
    Citri, Ami
    Harari, Daniel
    Shohat, Galit
    Ramakrishnan, Parameswaran
    Gan, Judith
    Lavi, Sara
    Eisenstein, Miriam
    Kimchi, Adi
    Wallach, David
    Pietrokovski, Shmuel
    Yarden, Yosef
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (20) : 14361 - 14369